Jul 25, 2024 | Ad-hoc, Featured news, Finance, News, Press
Group sales increase slightly to CHF 240.3 million (+0.2% compared to the prior-year period, +1.3% in local currencies). EBITDA at CHF 55.5 million (+5.6% compared to the prior-year period, +8.7% in local currencies) with a margin of 23.1% (prior-year period: 21.9%)....
Are you ready to dive into the fascinating universe of peptides and oligonucleotides?
Sign up for our newsletter and receive the latest updates directly in your inbox.
"*" indicates required fields